Abstract
Autism spectrum disorder (ASD) is a common heterogeneous neurodevelopmental disorder characterized by impairments in social development along with associated language delays, restrictive interests, and repetitive behaviors. Children diagnosed with ASD have an increased risk for co-occurring medical conditions including seizures, intellectual disability, and mood disorders. As early identification can improve outcomes in children with ASD, pediatricians who are at the forefront should screen and refer children at risk to subspecialists and appropriate support services for further evaluation and management. This review will discuss indications for screening, diagnostic considerations, the utility, and necessity of evaluations directed at identifying etiology of ASD, along with ASD-specific interventions and management of co-occurring medical conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013.
Maenner MJ, Shaw KA, Baio J. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2016. MMWR Surveill Summ. 2020;69(4):1.
Levy SE, Wolfe A, Coury D, Duby J, Farmer J, Schor E, et al. Screening tools for autism spectrum disorder in primary care: a systematic evidence review. Pediatrics. 2020;145(Suppl 1):S47–59.
Hyman SL, Levy SE, Myers SM. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics. 2020;145(1):e20193447.
Baio J. Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2010. 2014.
Zwaigenbaum L, Bauman ML, Fein D, Pierce K, Buie T, Davis PA, et al. Early screening of autism spectrum disorder: recommendations for practice and research. Pediatrics. 2015;136(Supplement 1):S41–59.
Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010;125(1):e17–23.
Kasari C, Gulsrud AC, Wong C, Kwon S, Locke J. Randomized controlled caregiver mediated joint engagement intervention for toddlers with autism. J Autism Dev Disord. 2010;40(9):1045–56.
Centers for Disease Control and Prevention. Autism spectrum disorder (ASD)—signs and symptoms 2019. https://www.cdc.gov/ncbddd/autism/signs.html.
Lord C, Brugha TS, Charman T, Cusack J, Dumas G, Frazier T, et al. Autism spectrum disorder. Nat Rev Dis Primers. 2020;6(1):1–23.
Robins D, Fein D, Barton M. Modified checklist for autism in toddlers, revised with follow-up. https://www.mchatscreen.com; 2009.
Filipek PA, Accardo PJ, Ashwal S, Baranek G, Cook E, Dawson G, et al. Practice parameter: screening and diagnosis of autism: report of the quality standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 2000;55(4):468–79.
Shulman C, Rice CE, Morrier MJ, Esler A. The role of diagnostic instruments in dual and differential diagnosis in autism spectrum disorder across the lifespan. Child Adolesc Psychiatr Clin. 2020;29(2):275–99.
Eaves LC, Wingert HD, Ho HH, Mickelson EC. Screening for autism spectrum disorders with the social communication questionnaire. J Dev Behav Pediatr. 2006;27(2):S95–S103.
Dai YG, Miller LE, Ramsey RK, Robins DL, Fein DA, Dumont-Mathieu T. Incremental utility of 24-month autism spectrum disorder screening after negative 18-month screening. J Autism Dev Disord. 2020;50(6):2030–40.
Mouti A, Dryer R, Kohn M. Differentiating autism spectrum disorder from ADHD using the social communication questionnaire. J Atten Disord. 2019;23(8):828–37.
Schwenck C, Freitag CM. Differentiation between attention-deficit/hyperactivity disorder and autism spectrum disorder by the social communication questionnaire. ADHD Attent Deficit Hyperactivity Disord. 2014;6(3):221–9.
Zwaigenbaum L, Bryson SE, Brian J, Smith IM, Roberts W, Szatmari P, et al. Stability of diagnostic assessment for autism spectrum disorder between 18 and 36 months in a high-risk cohort. Autism Res. 2016;9(7):790–800.
Havdahl KA, Bishop SL, Surén P, Øyen AS, Lord C, Pickles A, et al. The influence of parental concern on the utility of autism diagnostic instruments. Autism Res. 2017;10(10):1672–86.
Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014;53(2):237–57.
Schaefer GB, Mendelsohn NJ. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399–407.
Moeschler JB, Shevell M. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134(3):e903–18.
Manning M, Hudgins L. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010;12(11):742–5.
Ho KS, Wassman ER, Baxter AL, Hensel CH, Martin MM, Prasad A, et al. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders using an ultra-high resolution chromosomal microarray optimized for neurodevelopmental disorders. Int J Mol Sci. 2016;17(12):2070.
Tammimies K, Marshall CR, Walker S, Kaur G, Thiruvahindrapuram B, Lionel AC, et al. Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA. 2015;314(9):895–903.
Shen Y, Dies KA, Holm IA, Bridgemohan C, Sobeih MM, Caronna EB, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics. 2010;125(4):e727–35.
McGrew SG, Peters BR, Crittendon JA, Veenstra-VanderWeele J. Diagnostic yield of chromosomal microarray analysis in an autism primary care practice: which guidelines to implement? J Autism Dev Disord. 2012;42(8):1582–91.
Stone WL, Basit H, Los E. Fragile X syndrome. StatPearls. Treasure Island: StatPearls Publishing. Copyright © 2020, StatPearls Publishing LLC; 2020.
Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the quality standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003;60(3):367–80.
Schiff M, Benoist J-F, Aïssaoui S, Boepsflug-Tanguy O, Mouren M-C, De Baulny HO, et al. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS One. 2011;6(7):e21932.
Hadjixenofontos A, Schmidt MA, Whitehead PL, Konidari I, Hedges DJ, Wright HH, et al. Evaluating mitochondrial DNA variation in autism spectrum disorders. Ann Hum Genet. 2013;77(1):9–21.
Campistol J, Díez-Juan M, Callejón L, Fernandez-De Miguel A, Casado M, Garcia Cazorla A, et al. Inborn error metabolic screening in individuals with nonsyndromic autism spectrum disorders. Dev Med Child Neurol. 2016;58(8):842–7.
García-Cazorla A, Oyarzabal A, Fort J, Robles C, Castejón E, Ruiz-Sala P, et al. Two novel mutations in the BCKDK (branched-chain keto-acid dehydrogenase kinase) gene are responsible for a neurobehavioral deficit in two pediatric unrelated patients. Hum Mutat. 2014;35(4):470–7.
van Karnebeek CD, Stockler S. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. Mol Genet Metab. 2012;105(3):368–81.
Cario H, Smith DE, Blom H, Blau N, Bode H, Holzmann K, et al. Dihydrofolate reductase deficiency due to a homozygous DHFR mutation causes megaloblastic anemia and cerebral folate deficiency leading to severe neurologic disease. Am J Hum Genet. 2011;88(2):226–31.
Ziats MN, Comeaux MS, Yang Y, Scaglia F, Elsea SH, Sun Q, et al. Improvement of regressive autism symptoms in a child with TMLHE deficiency following carnitine supplementation. Am J Med Genet A. 2015;167(9):2162–7.
Flinn AM, Gennery AR. Adenosine deaminase deficiency: a review. Orphanet J Rare Dis. 2018;13(1):1–7.
Legido A, Jethva R, Goldenthal MJ, editors. Mitochondrial dysfunction in autism. Seminars in pediatric neurology. Elsevier; 2013.
Jiang Y-H, Wang Y, Xiu X, Choy KW, Pursley AN, Cheung SW. Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era. Crit Rev Clin Lab Sci. 2014;51(5):249–62.
Frye RE. Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder. Epilepsy Behav. 2015;47:147–57.
Wong C, Odom SL, Hume KA, Cox AW, Fettig A, Kucharczyk S, et al. Evidence-based practices for children, youth, and young adults with autism spectrum disorder: a comprehensive review. J Autism Dev Disord. 2015;45(7):1951–66.
Smith T, Eikeseth SO. Ivar Lovaas: pioneer of applied behavior analysis and intervention for children with autism. J Autism Dev Disord. 2011;41(3):375–8.
Linstead E, Dixon DR, French R, Granpeesheh D, Adams H, German R, et al. Intensity and learning outcomes in the treatment of children with autism spectrum disorder. Behav Modif. 2017;41(2):229–52.
Orinstein AJ, Helt M, Troyb E, Tyson KE, Barton ML, Eigsti I-M, et al. Intervention for optimal outcome in children and adolescents with a history of autism. J Dev Behav Pediatr. 2014;35(4):247–56.
Bearss K, Johnson C, Smith T, Lecavalier L, Swiezy N, Aman M, et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial. JAMA. 2015;313(15):1524–33.
Tager-Flusberg H, Kasari C. Minimally verbal school-aged children with autism spectrum disorder: the neglected end of the spectrum. Autism Res. 2013;6(6):468–78.
Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392(10146):508–20.
El Achkar CM, Spence SJ. Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy. Epilepsy Behav. 2015;47:183–90.
Ghacibeh GA, Fields C. Interictal epileptiform activity and autism. Epilepsy Behav. 2015;47:158–62.
Miano S, Ferri R. Epidemiology and management of insomnia in children with autistic spectrum disorders. Pediatr Drugs. 2010;12(2):75–84.
Cohen S, Conduit R, Lockley SW, Rajaratnam SM, Cornish KM. The relationship between sleep and behavior in autism spectrum disorder (ASD): a review. J Neurodev Disord. 2014;6(1):44.
Blackmer AB, Feinstein JA. Management of sleep disorders in children with neurodevelopmental disorders: a review. Pharmacotherapy. 2016;36(1):84–98.
Malow BA, Adkins KW, Reynolds A, Weiss SK, Loh A, Fawkes D, et al. Parent-based sleep education for children with autism spectrum disorders. J Autism Dev Disord. 2014;44(1):216–28.
Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci. 2013;14(10):20508–42.
Malow B, Adkins KW, McGrew SG, Wang L, Goldman SE, Fawkes D, et al. Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes. J Autism Dev Disord. 2012;42(8):1729–37.
Loh AR, Chiang MF. Pediatric vision screening. Pediatr Rev. 2018;39(5):225.
Swanson MW, Lee SD, Frazier MG, Bade A, Coulter RA. Vision screening among children with autism spectrum disorder. Optom Vis Sci. 2020;97(11):917–28.
Buie T, Campbell DB, Fuchs GJ, Furuta GT, Levy J, VandeWater J, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125(Suppl 1):S1–S18.
Chaidez V, Hansen RL, Hertz-Picciotto I. Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord. 2014;44(5):1117–27.
Bandini LG, Anderson SE, Curtin C, Cermak S, Evans EW, Scampini R, et al. Food selectivity in children with autism spectrum disorders and typically developing children. J Pediatr. 2010;157(2):259–64.
Sharp WG, Berry RC, McCracken C, Nuhu NN, Marvel E, Saulnier CA, et al. Feeding problems and nutrient intake in children with autism spectrum disorders: a meta-analysis and comprehensive review of the literature. J Autism Dev Disord. 2013;43(9):2159–73.
Hyman SL, Stewart PA, Schmidt B, Lemcke N, Foley JT, Peck R, et al. Nutrient intake from food in children with autism. Pediatrics. 2012;130(Suppl 2):S145–53.
Zuckerman KE, Hill AP, Guion K, Voltolina L, Fombonne E. Overweight and obesity: prevalence and correlates in a large clinical sample of children with autism spectrum disorder. J Autism Dev Disord. 2014;44(7):1708–19.
Du RY, Yiu CK, King NM. Oral health behaviours of preschool children with autism spectrum disorders and their barriers to dental care. J Autism Dev Disord. 2019;49(2):453–9.
Doehring P, Reichow B, Palka T, Phillips C, Hagopian L. Behavioral approaches to managing severe problem behaviors in children with autism spectrum and related developmental disorders: a descriptive analysis. Child Adolesc Psychiatr Clin. 2014;23(1):25–40.
Chen C, Shen YD, Xun GL, Cai WX, Shi LJ, Xiao L, et al. Aggressive behaviors and treatable risk factors of preschool children with autism spectrum disorder. Autism Res. 2017;10(6):1155–62.
Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA. Aggression in autism spectrum disorder: presentation and treatment options. 2016.
Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, et al. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol. 2008;36(1):117–28.
Vasa RA, Mazurek MO, Mahajan R, Bennett AE, Bernal MP, Nozzolillo AA, et al. Assessment and treatment of anxiety in youth with autism spectrum disorders. Pediatrics. 2016;137(Suppl 2):S115–23.
Segers M, Rawana J. What do we know about suicidality in autism spectrum disorders? A systematic review. Autism Res. 2014;7(4):507–21.
De-la-Iglesia M, Olivar J-S. Risk factors for depression in children and adolescents with high functioning autism spectrum disorders. ScientificWorldJournal. 2015;2015:127853.
Ozonoff S, Young GS, Landa RJ, Brian J, Bryson S, Charman T, et al. Diagnostic stability in young children at risk for autism spectrum disorder: a baby siblings research consortium study. J Child Psychol Psychiatry. 2015;56(9):988–98.
Anderson DK, Liang JW, Lord C. Predicting young adult outcome among more and less cognitively able individuals with autism spectrum disorders. J Child Psychol Psychiatry. 2014;55(5):485–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kim, A., Rajan, D.S. (2022). Child with Suspected Autism. In: Kamat, D.M., Sivaswamy, L. (eds) Symptom-Based Approach to Pediatric Neurology . Springer, Cham. https://doi.org/10.1007/978-3-031-10494-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-10494-7_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-10493-0
Online ISBN: 978-3-031-10494-7
eBook Packages: MedicineMedicine (R0)